Baylor College of Medicine: Clinical Trial Uses Immunotherapy to Treat Mesothelioma
July 24, 2019
July 24, 2019
HOUSTON, Texas, July 24 [TNSmedicalresearch] -- The Baylor College of Medicine issued the following news release:
Malignant pleural mesothelioma, an aggressive cancer that affects the lining of the lungs, is fatal in most cases. The majority of patients will die within a year and a half of diagnosis. The Mesothelioma Treatment Center at the Baylor College of Medicine Lung Institute is testing a new treatment that combines immunotherapy with a new drug that accelerates cell death. Re . . .
Malignant pleural mesothelioma, an aggressive cancer that affects the lining of the lungs, is fatal in most cases. The majority of patients will die within a year and a half of diagnosis. The Mesothelioma Treatment Center at the Baylor College of Medicine Lung Institute is testing a new treatment that combines immunotherapy with a new drug that accelerates cell death. Re . . .